U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
109281
Substance Class Protein
Created
by admin
on Fri Jun 25 21:41:46 UTC 2021
Edited
by admin
on Fri Jun 25 21:41:46 UTC 2021
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
SEV29N8JND
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H MEMBER 2
Common Name English
H-ERG
Common Name English
ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL 1
Common Name English
HERG
Common Name English
HERG-1
Common Name English
Code System Code Type Description
FDA UNII
SEV29N8JND
Created by admin on Fri Jun 25 21:41:46 UTC 2021 , Edited by admin on Fri Jun 25 21:41:46 UTC 2021
PRIMARY
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_598
Related Record Type Details
Structure of N-DESMETHYLAPALUTAMIDE
INHIBITOR->OFF-TARGET
Structure of BMS-986142
INHIBITOR->OFF-TARGET
Structure of LUXEPTINIB
INHIBITOR->OFF-TARGET
IC50
Structure of DESMETHYLASTEMIZOLE
INHIBITOR->OFF-TARGET
MIK-665
NON-INHIBITOR->OFF TARGET
Structure of AVAPRITINIB
INHIBITOR->OFF-TARGET
Structure of BEDAQUILINE
INHIBITOR->OFF-TARGET
IC50
Structure of APOMORPHINE
INHIBITOR->OFF-TARGET
Structure of AVANAFIL
INHIBITOR->OFF-TARGET
Avanafil inhibited hERG current in a concentration-dependent manner with IC50 of 15.8 ?M, which corresponded to exposures approximately 290-fold above the unbound Cmax (~26 ng/mL, 0.054 ?M) in human subjects after the maximum recommended single oral dose at 200 mg.
IC50
Structure of ASTEMIZOLE
INHIBITOR->OFF-TARGET
Structure of APALUTAMIDE
INHIBITOR->OFF-TARGET
Structure of AMIODARONE
INHIBITOR -> TARGET
Structure of POSELTINIB
INHIBITOR->OFF-TARGET
Structure of LORLATINIB
NON-INHIBITOR->OFF TARGET
did not predict QTc prolongation, by inhibition of the hERG channel at clinically relevant concentrations
Structure of ACALABRUTINIB
NON-INHIBITOR->OFF TARGET
Structure of TAFENOQUINE
INHIBITOR -> TARGET
IC50
Structure of TECASTEMIZOLE
INHIBITOR->OFF-TARGET
Structure of CEP-40783
NON-INHIBITOR->OFF TARGET
Structure of SSR-181507
INHIBITOR->OFF-TARGET
Structure of NETARSUDIL
INHIBITOR->OFF-TARGET
Structure of MORPHOTHIADINE
INHIBITOR->OFF-TARGET
IC50
ERVOGASTAT
NON-INHIBITOR->OFF TARGET
Structure of E-4031
INHIBITOR -> TARGET
Structure of BETRIXABAN
INHIBITOR->OFF-TARGET
MIK-665
TRANSPORTER -> NON-INHIBITOR
Structure of W-18
INHIBITOR -> TARGET
HM-43239
INHIBITOR->OFF-TARGET
Structure of TP-3654
NON-INHIBITOR->OFF TARGET
IC50
Structure of AZD-1390
INHIBITOR->OFF-TARGET
IC50
Structure of RISDIPLAM
NON-INHIBITOR->OFF TARGET
VEBRELTINIB
INHIBITOR -> TRANSPORTER
Structure of N-MONODESMETHYL BEDAQUILINE
INHIBITOR->OFF-TARGET
MAY BE RESPONSIBLE FOR QT PROLONGATION
IC50
Structure of TD-2749
NON-INHIBITOR->OFF TARGET
9% inhibition at 3 MICROMOLAR
IC50
Structure of IBUTILIDE
INHIBITOR -> TARGET
Structure of GIREDESTRANT
INHIBITOR->OFF-TARGET
Structure of BOSUTINIB
INHIBITOR->OFF-TARGET
SUN-1334
NON-INHIBITOR->OFF TARGET
IC50
Structure of PF-06821497
NON-INHIBITOR->OFF TARGET
Structure of VERUBECESTAT
INHIBITOR->OFF-TARGET
Structure of CIFENLINE
INHIBITOR -> TARGET
IC50
ERVOGASTAT
NON-INHIBITOR -> TRANSPORTER
Structure of SOTALOL
INHIBITOR -> TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966